Allied Market Research
Loading...
Cart
0
New
New Allied Market Research

Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product Type (Software and Device), and Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)): Global Opportunity Analysis and Industry Forecast, 2020–2027

A01787
Pages: 280
Sep 2020 | 14986 Views
 
Author(s) : Surabhi Pandey, Sahil Sinha , Onkar Sumant
Tables: 130
Charts: 42
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Digital Therapeutics Market

Request Now !

Digital Therapeutics Market Overview:

The global digital therapeutics market size was valued at $2.88 billion in 2019, and is expected to reach $13.80 billion by 2027 with a CAGR of 20.5% during the forecast period.

Digital therapeutics is a subdivision of digital health, and not all digital health solutions are digital therapeutics. The difference between digital health and digital therapeutics is based on clinical outcomes for patients. For instance, digital therapeutics does not include consumer health-oriented technologies such as step-counters and calorie-counters. It is a new class of healthcare products that uses digital technology to prevent, manage, or treat medical conditions. In addition, it utilizes digital health technologies to treat a psychological condition. Hence, these aforementioned factors help in increasing the global digital therapeutics market share across the world. 

Digital-Therapeutics-Market-2020-2027

Get more information on this report : Request Sample Pages

 

The demand for global digital therapeutics is on the rise, owing to increase in adoption of smartphones and tablets, coupled with healthcare apps; growth in need to control healthcare costs; and rise in incidences of chronic diseases. However, lack of awareness regarding digital therapeutics in developing countries and patient data privacy concerns restrain the market growth. On the contrary, high growth opportunities in untapped markets are expected to provide significant profitable opportunities for manufacturers in the digital therapeutics industry.

The COVID-19 pandemic disrupted healthcare system all over the world and as health responses to the pandemic are strengthened, a need for a substantial shift to apps and hardware capable for lifestyle enhancement and medical intervention, with potentially life-saving functionalities has emerged. The digital therapeutics market is expected to be positively impacted by the COVID-19 pandemic, owing to awareness regarding importance of digital health, rise in prevalence of mental illness, and increase in rate of drug abuse globally. Moreover, during this pandemic, people are required to stay at home, which leads to less physical activity, unhealthy lifestyle, and mental stress and, in turn, increase in prevalence of chronic diseases. Hence, there is a rise in demand for DTx devices and software across the globe.

Digital Therapeutics Market
By Application

Your browser does not support the canvas element.

Diabetes holds the dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Application segment review

On the basis of application, the digital therapeutics market is segmented into diabetes, obesity, cardiovascular disease, central nervous system disease, respiratory disease, smoking cessation, gastrointestinal disorder, and others. The diabetes segment was the major revenue contributor in 2019, and is anticipated to continue this trend during the forecast period, owing to high prevalence of diabetes. In addition, demand for cost-effective healthcare options and highest comparative prevalence rates for diabetes are observed in North America, the Middle East, and North Africa, which further boosts the demand for digital therapeutics among diabetic patients in these regions. However, the obesity segment is projected to exhibit the highest growth during the forecast period. This is attributed to increase in number of overweight populations, which increases the number of chronic diseases, owing to obesity. In addition, better accessibility of digital therapeutics software application help patients to maintain their proper diet as well as track health data and daily physical activities. Moreover, the software application provides regular online assistance from certified doctors, which is expected to help in reducing prevalence of obesity in the future. Furthermore, several companies have launched a variety of digital therapeutics products. For instance, in 2017, Oxil launched an app to tackle increasing cases of obesity among youth. Moreover, Azumio provides fitness buddy mobile app that offers largest exercise database, which helps reduce obesity. The analysis done by Noom Inc. demonstrated that 78% of users lost weight with its mobile health coaching solutions.

Digital Therapeutics Market
By Product

Your browser does not support the canvas element.

Software segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Product segment review

Depending on product, the digital therapeutics market is categorized into software and devices. The software segment is projected to exhibit the highest growth during the forecast period. This is attributed to rise in demand for reducing healthcare costs across the world. This gives immense opportunities to developers to use existing software and develop new and advanced features to make them more effective and affordable. Thus, is anticipated to help in increasing the digital therapeutics market size in the future.

Digital Therapeutics Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific region would exhibit the highest CAGR of 22.2% during 2020-2027.

Get more information on this report : Request Sample Pages

Region segment review

Region wise, the digital therapeutics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2019, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to increase in geriatric population, rise in incidences of chronic diseases, surge in demand for wireless & portable systems, and availability of sophisticated reimbursement structure that aims in reducing expenditure.

The report provides a comprehensive analysis of the key players operating in the global digital therapeutics market, namely 2MORROW, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., Fitbit, Inc. (Twine Health, Inc.), Happify, Inc., Kaia Health, Livongo Health, Inc., Medtronic Plc., Omada Health, Inc., Pear Therapeutics, Inc., Proteus Digital Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Welldoc, Inc. The other players in the value chain include (profiles not included in the report) Canary Health Inc., Mango Health Inc., Noom, Inc., and Dthera Sciences.

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current digital therapeutics market trends and forecast estimations from 2019 to 2027, which assists to identify the prevailing market opportunities. 
  • An in-depth digital therapeutics market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
  • Region-wise and country-wise market conditions are comprehensively analyzed in this report.
  • The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2027, in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the digital therapeutics market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of global digital therapeutics market.

Key Market Segments

By Application

  • Diabetes
  • Obesity
  • Cardiovascular Disease (CVD)
  • Central Nervous System (CNS) Disease
  • Respiratory Disease
  • Smoking Cessation
  • Gastrointestinal Disorder (GID)
  • Others

By Product Type

  • Software
  • Device

By Sales Channel

  • Business-to-Business (B2B)
    • Employer
    • Healthcare Provider
    • Others
  • Business-to-Consumer (B2C)
    • Patient
    • Caregiver

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Japan
    • India
    • China
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • Turkey
    • Saudi Arabia 
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key Market Segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Top player positioning, 2019
3.4.Porter’s five forces analysis
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in adoption of smartphones and tablets, coupled with healthcare apps
3.5.1.2.Growth in need to control healthcare costs
3.5.1.3.Rise in incidences of chronic diseases

3.5.2.Restraints

3.5.2.1.Lack of awareness regarding digital therapeutics in developing countries
3.5.2.2.Patient data privacy concerns

3.5.3.Opportunity

3.5.3.1.Emerging markets offer significant growth opportunities

3.6.Impact analysis of COVID-19 on the digital therapeutics market
3.7.Impact of government regulations on global digital therapeutics market

3.7.1.U.S. FDA’s premarket clearance and approval requirements
3.7.2.European Union premarket clearance and approval requirements
3.7.3.Japan premarket clearance and approval requirements

3.8.Strategy adopted by top 10 start-ups

3.8.1.Meru Health, Inc.
3.8.2.Bold Health Limited
3.8.3.BehaVR, LLC
3.8.4.Naluri Hidup Sdn Bhd
3.8.5.Big Health
3.8.6.Hinge Health, Inc.
3.8.7.Glooko, Inc.
3.8.8.Holmusk Pte. Ltd.
3.8.9.Wellthy Therapeutics Pvt Ltd.
3.8.10.Virta Health Corp.

3.9.Key digital technologies for digital therapeutics

3.9.1.Mobile health (mHealth)
3.9.2.Personalized healthcare
3.9.3.Digital Cognitive Behavior Therapy (CBT)
3.9.4.Wearable devices and sensors

3.10.Necessary human resources required for digital therapeutics development
3.11.Usage of patient data acquired from digital therapeutics

3.11.1.Types of personal information that are collected by DTx companies

CHAPTER 4:DIGITAL THERAPEUTICS MARKET, BY APPLICATION

4.1.Overview

4.1.1.Market size and forecast

4.2.Diabetes

4.2.1.Key market trends and growth opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Obesity

4.3.1.Key market trends and growth opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Cardiovascular diseases

4.4.1.Key market trends and growth opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

4.5.Central nervous system (CNS) diseases

4.5.1.Key market trends and growth opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country

4.6.Gastrointestinal disorder

4.6.1.Key market trends and growth opportunities
4.6.2.Market size and forecast
4.6.3.Market analysis, by country

4.7.Respiratory diseases

4.7.1.Key market trends and growth opportunities
4.7.2.Market size and forecast
4.7.3.Market analysis, by country

4.8.Smoking cessation

4.8.1.Key market trends and growth opportunities
4.8.2.Market size and forecast
4.8.3.Market analysis, by country

4.9.Others

4.9.1.Key market trends and growth opportunities
4.9.2.Market size and forecast
4.9.3.Market analysis, by country

CHAPTER 5:DIGITAL THERAPEUTICS MARKET, BY PRODUCT

5.1.Overview

5.1.1.Market size and forecast

5.2.Software

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Devices

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

CHAPTER 6:DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL

6.1.Overview

6.1.1.Market size and forecast

6.2.Business-to-business (B2B)

6.2.1.Market size and forecast, by type

6.2.1.1.Employer

6.2.1.1.1.Market size and forecast

6.2.1.2.Healthcare Providers

6.2.1.2.1.Market size and forecast

6.2.1.3.Others

6.2.1.3.1.Market size and forecast

6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Business-to-consumers

6.3.1.Market size and forecast, by type

6.3.1.1.Patients

6.3.1.1.1.Market size and forecast

6.3.1.2.Caregivers

6.3.1.2.1.Market size and forecast

6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

CHAPTER 7:DIGITAL THERAPEUTICS MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America digital therapeutics market, by country

7.2.2.1.U.S. digital therapeutics market, by application
7.2.2.2.U.S digital therapeutics market, by product type
7.2.2.3.U.S. digital therapeutics market, by sales channel
7.2.2.4.Canada digital therapeutics market, by application
7.2.2.5.Canada digital therapeutics market, by product type
7.2.2.6.Canada digital therapeutics market, by sales channel
7.2.2.7.Mexico digital therapeutics market, by application
7.2.2.8.Mexico digital therapeutics market, by product type
7.2.2.9.Mexico digital therapeutics market, by sales channel

7.2.3.North America digital therapeutics market, by application
7.2.4.North America digital therapeutics market, by product type
7.2.5.North America digital therapeutics market, by sales channel

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe digital therapeutics market, by country

7.3.2.1.UK digital therapeutics market, by application
7.3.2.2.UK digital therapeutics market, by product type
7.3.2.3.UK digital therapeutics market, by sales channel
7.3.2.4.Germany digital therapeutics market, by application
7.3.2.5.Germany digital therapeutics market, by product type
7.3.2.6.Germany digital therapeutics market, by sales channel
7.3.2.7.France digital therapeutics market, by application
7.3.2.8.France digital therapeutics market, by product type
7.3.2.9.France digital therapeutics market, by sales channel
7.3.2.10.Italy digital therapeutics market, by application
7.3.2.11.Italy digital therapeutics market, by product type
7.3.2.12.Italy digital therapeutics market, by sales channel
7.3.2.13.Spain digital therapeutics market, by application
7.3.2.14.Spain digital therapeutics market, by product type
7.3.2.15.Spain digital therapeutics market, by sales channel
7.3.2.16.Rest of Europe digital therapeutics market, by application
7.3.2.17.Rest of Europe digital therapeutics market, by product type
7.3.2.18.Rest of Europe digital therapeutics market, by sales channel

7.3.3.Europe digital therapeutics market, by application
7.3.4.Europe digital therapeutics market, by product type
7.3.5.Europe digital therapeutics market, by sales channel

7.4.Asia-pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific digital therapeutics market, by country
7.4.2.1.Japan digital therapeutics market, by application
7.4.2.2.Japan digital therapeutics market, by product type
7.4.2.3.Japan digital therapeutics market, by sales channel
7.4.2.4.China digital therapeutics market, by application
7.4.2.5.China digital therapeutics market, by product type
7.4.2.6.China digital therapeutics market, by sales channel
7.4.2.7.Australia digital therapeutics market, by application
7.4.2.8.Australia digital therapeutics market, by product type
7.4.2.9.Australia digital therapeutics market, by sales channel
7.4.2.10.India digital therapeutics market, by application
7.4.2.11.India digital therapeutics market, by product type
7.4.2.12.India digital therapeutics market, by sales channel
7.4.2.13.South Korea digital therapeutics market, by application
7.4.2.14.South Korea digital therapeutics market, by product type
7.4.2.15.South Korea digital therapeutics market, by sales channel
7.4.2.16.Rest of Asia-Pacific digital therapeutics market, by application
7.4.2.17.Rest of Asia-Pacific digital therapeutics market, by product type
7.4.2.18.Rest of Asia-Pacific digital therapeutics market, by sales channel

7.4.3.Asia-Pacific digital therapeutics market, by application
7.4.4.Asia-Pacific digital therapeutics market, by product type
7.4.5.Asia-Pacific digital therapeutics market, by sales channel

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA digital therapeutics market, by country
7.5.2.1.Brazil digital therapeutics market, by application
7.5.2.2.Brazil digital therapeutics market, by product type
7.5.2.3.Brazil digital therapeutics market, by sales channel
7.5.2.4.Turkey digital therapeutics market, by application
7.5.2.5.Turkey digital therapeutics market, by product type
7.5.2.6.Turkey digital therapeutics market, by sales channel
7.5.2.7.Saudi Arabia digital therapeutics market, by application
7.5.2.8.Saudi Arabia digital therapeutics market, by product type
7.5.2.9.Saudi Arabia digital therapeutics market, by sales channel
7.5.2.10.South Africa digital therapeutics market, by application
7.5.2.11.South Africa digital therapeutics market, by product type
7.5.2.12.South Africa digital therapeutics market, by sales channel
7.5.2.13.Rest of LAMEA digital therapeutics market, by application
7.5.2.14.Rest of LAMEA digital therapeutics market, by product type
7.5.2.15.Rest of LAMEA digital therapeutics market, by sales channel

7.5.3.LAMEA digital therapeutics market, by application
7.5.4.LAMEA digital therapeutics market, by product type
7.5.5.LAMEA digital therapeutics market, by sales channel

CHAPTER 8:COMPANY PROFILES

8.1.2MORROW, INC.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Key strategic moves and developments

8.2.AKILI INTERACTIVE LABS, INC.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Product portfolio
8.2.4.Key strategic moves and developments

8.3.CLICK THERAPEUTICS, INC.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments

8.4.FITBIT, INC. (TWINE HEALTH, INC.)

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Product portfolio
8.4.4.Business performance
8.4.5.Key strategic moves and developments

8.5.HAPPIFY, INC.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Product portfolio
8.5.4.Key strategic moves and developments

8.6.KAIA HEALTH

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Product portfolio
8.6.4.Key strategic moves and developments

8.7.LIVONGO HEALTH, INC.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Product portfolio
8.7.4.Key strategic moves and developments

8.8.MEDTRONIC PLC.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.OMADA HEALTH, INC.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Key strategic moves and developments

8.10.PEAR THERAPEUTICS, INC.

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Product portfolio
8.10.4.Key strategic moves and developments

8.11.PROTEUS DIGITAL HEALTH, INC.

8.11.1.Company overview
8.11.2.Company snapshot
8.11.3.Operating business segments
8.11.4.Product portfolio
8.11.5.Key strategic moves and developments

8.12.RESMED, INC. (PROPELLER HEALTH)

8.12.1.Company overview
8.12.2.Company snapshot
8.12.3.Operating business segments
8.12.4.Product portfolio
8.12.5.Business performance
8.12.6.Key strategic moves and developments

8.13.VOLUNTIS, INC.

8.13.1.Company overview
8.13.2.Company snapshot
8.13.3.Operating business segments
8.13.4.Product portfolio
8.13.5.Business performance
8.13.6.Key strategic moves and developments

8.14.WELLDOC, INC.

8.14.1.Company overview
8.14.2.Company snapshot
8.14.3.Operating business segments
8.14.4.Product portfolio
8.14.5.Key strategic moves and developments

LIST OF TABLES

TABLE 01.FDA CLASSIFICATION OF MEDICAL DEVICES
TABLE 02.DIGITAL SKILLS REQUIRED FOR EMPLOYEES DEDICATED FOR DTX DEVELOPMENTS
TABLE 03.RANGE OF NUMBER OF EMPLOYEES WITH DIGITAL SKILLS DEDICATED FOR DIGITAL THERAPEUTICS DEVELOPMENTS, BY COMPANY
TABLE 04.GLOBAL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 05.DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 2019–2027 ($MILLION)
TABLE 06.DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 2019–2027 ($MILLION)
TABLE 07.DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2019–2027 ($MILLION)
TABLE 08.DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY REGION, 2019–2027 ($MILLION)
TABLE 09.SMART PILLS FOR CAPSULE ENDOSCOPY, DRUG DELIVERY, AND PATIENT MONITORING AVAILABLE IN THE MARKET
TABLE 10.DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY REGION, 2019–2027 ($MILLION)
TABLE 11.DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2019–2027 ($MILLION)
TABLE 12.DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 2019–2027 ($MILLION)
TABLE 13.DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 14.GLOBAL DIGITAL THERAPEUTICS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 15.DIGITAL THERAPEUTIC APPLICATIONS AND SOFTWARE PLATFORMS
TABLE 16.GLOBAL DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY REGION, 2019–2027 ($MILLION)
TABLE 17.GLOBAL DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 18.GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 19.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY TYPE, 2019–2027 ($MILLION)
TABLE 20.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY REGION, 2019–2027 ($MILLION)
TABLE 21.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY TYPE, 2019–2027 ($MILLION)
TABLE 22.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY REGION, 2019–2027 ($MILLION)
TABLE 23.DIGITAL THERAPEUTICS MARKET REVENUE, BY REGION, 2019–2027 ($MILLION)
TABLE 24.NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 25.U.S. DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 26.U.S. DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 27.U.S. DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 28.CANADA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 29.CANADA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 30.CANADA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 31.MEXICO DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 32.MEXICO DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 33.MEXICO DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 34.NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 35.NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 36.NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 37.EUROPE DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 38.UK DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 39.UK DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 40.UK DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 41.GERMANY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 42.GERMANY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 43.GERMANY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 44.FRANCE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 45.FRANCE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 46.FRANCE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 47.ITALY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 48.ITALY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 49.ITALY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 50.SPAIN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 51.SPAIN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 52.SPAIN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 53.REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 54.REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 55.REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 56.EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 57.EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 58.EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 59.ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 60.JAPAN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 61.JAPAN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 62.JAPAN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 63.CHINA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 64.CHINA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 65.CHINA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 66.AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 67.AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 68.AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 69.INDIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 70.INDIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 71.INDIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 72.SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 73.SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 74.SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 75.REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 76.REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 77.REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 78.ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 79.ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 80.ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 81.LAMEA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 82.BRAZIL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 83.BRAZIL DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 84.BRAZIL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 85.TURKEY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 86.TURKEY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 87.TURKEY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 88.SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 89.SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 90.SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 91.SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 92.SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 93.SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 94.REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 95.REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 96.REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 97.LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 98.LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 99.LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019–2027 ($MILLION)
TABLE 100.2MORROW: COMPANY SNAPSHOT
TABLE 101.WELLDOC: PRODUCT PORTFOLIO
TABLE 102.AKILI: COMPANY SNAPSHOT
TABLE 103.AKILI: PRODUCT PORTFOLIO
TABLE 104.CLICK THERAPEUTICS: COMPANY SNAPSHOT
TABLE 105.CLICK THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 106.FITBIT: COMPANY SNAPSHOT
TABLE 107.FITBIT: PRODUCT PORTFOLIO
TABLE 108.HAPPIFY: COMPANY SNAPSHOT
TABLE 109.HAPPIFY: PRODUCT PORTFOLIO
TABLE 110.KAIA: COMPANY SNAPSHOT
TABLE 111.KAIA: PRODUCT PORTFOLIO
TABLE 112.LIVONGO: COMPANY SNAPSHOT
TABLE 113.LIVONGO: PRODUCT PORTFOLIO
TABLE 114.MEDTRONIC: COMPANY SNAPSHOT
TABLE 115.MEDTRONIC: OPERATING SEGMENTS
TABLE 116.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 117.OMADA: COMPANY SNAPSHOT
TABLE 118.OMADA: PRODUCT PORTFOLIO
TABLE 119.PEAR: COMPANY SNAPSHOT
TABLE 120.PEAR: PRODUCT PORTFOLIO
TABLE 121.PROTEUS: COMPANY SNAPSHOT
TABLE 122.PROTEUS: PRODUCT PORTFOLIO
TABLE 123.RESMED: COMPANY SNAPSHOT
TABLE 124.RESMED: OPERATING SEGMENTS
TABLE 125.RESMED: PRODUCT PORTFOLIO
TABLE 126.VOLUNTIS: COMPANY SNAPSHOT
TABLE 127.VOLUNTIS: OPERATING SEGMENTS
TABLE 128.VOLUNTIS: PRODUCT PORTFOLIO
TABLE 129.WELLDOC: COMPANY SNAPSHOT
TABLE 130.WELLDOC: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.DIGITAL THERAPEUTICS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKET IN DIGITAL THERAPEUTICS MARKET, 2019
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2016–2020*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016–2020* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2016–2020*
FIGURE 06.TOP PLAYER POSITIONING, 2019
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH BARGAINING POWER OF BUYERS
FIGURE 09.LOW THREAT OF SUBSTITUTION
FIGURE 10.MODERATE THREAT OF NEW ENTRANT
FIGURE 11.MODERATE COMPETITIVE RIVALRY
FIGURE 12.GLOBAL DIGITAL THERAPEUTICS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY
FIGURE 13.DIGITAL THERAPEUTICS MARKET, BY APPLICATION
FIGURE 14.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY COUNTRY,  2019 & 2027, ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER,  BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY COUNTRY,  2019 & 2027 ($MILLION)
FIGURE 22.DIGITAL THERAPEUTICS MARKET, BY PRODUCT
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY COUNTRY,  2017 & 2024 (%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY COUNTRY,  2019 & 2027 (%)
FIGURE 25.DIGITAL THERAPEUTICS MARKET BY SALES CHANNEL
FIGURE 26.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY EMPLOYER,  2019–2027 ($MILLION)
FIGURE 27.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY HEALTHCARE PROVIDERS, 2019–2027 ($MILLION)
FIGURE 28.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY OTHERS,  2019–2027 ($MILLION)
FIGURE 29.COMPARATIVE ANALYSIS OF BUSINESS-TO-BUSINESS MARKET, BY COUNTRY 2019 & 2027 ($MILLION)
FIGURE 30.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY PATIENTS,  2019–2027 ($MILLION)
FIGURE 31.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY CAREGIVERS,  2019–2027 ($MILLION)
FIGURE 32.COMPARATIVE ANALYSIS OF BUSINESS-TO-CONSUMERS, BY COUNTRY 2019 & 2027 ($MILLION)
FIGURE 33.FITBIT: NET SALES, 2017–2019 ($MILLION)
FIGURE 34.FITBIT: NET SALES, BY REGION, 2019 (%)
FIGURE 35.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 36.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 37.MEDTRONIC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 38.RESMED: NET SALES, 2018–2020 ($MILLION)
FIGURE 39.RESMED: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 40.VOLUNTIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.VOLUNTIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.VOLUNTIS: REVENUE SHARE, BY REGION, 2019 (%)

 
 

The field of digital therapeutics is still young and has gained significant attention over the years. The digital therapeutics market has piqued the interest of healthcare providers, patients, and practitioners, owing to several benefits offered by these devices to reduce healthcare expenditure, improve patient & doctor communication, and manage patient health efficiently. There have been remarkable technological advancements in development of novel digital therapeutics applications to provide advanced management options for chronic disease patients and to maintain healthy lifestyles. As the market is saturated and is growing at a steady rate in developed nations, Asia-Pacific and LAMEA are expected to offer high growth opportunities to key players in this market.

Furthermore, significant advancements in the applications of digital therapeutic products with increase in clinically backed researches and advanced hardware and software are projected to increase the usage rate of digital therapeutics globally. Presently, rapid adoption of digital therapeutics is witnessed in the world for use of novel apps for wellness management such as fitness, diet & nutrition, diabetes, obesity, sleep apnea, respiratory disorder, and lifestyle & stress.

 
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The market value of global digital therapeutics market was $2.88 billion in 2019

A. The forecast period is from 2020 to 2027.

A. The market value of global digital therapeutics market in 2020 is $3.73 billion.

A. the adoption of advanced smartphone applications and smart devices of digital therapeutics is expected to increase due to rise in incidence of chronic diseases such as diabetes and obesity.

A. The base year is 2019 in digital therapeutics market

A. Increase in adoption of smartphones and tablets coupled with healthcare applications

A. Emerging countries of Asia-Pacific region are growing at a growth% of 22.2%. India and China are expected to grow at a CAGR of 26.1%, 23.7% respectively.

A. The North America market held a major share in the digital therapeutics market in 2019 and is expected to continue the trend in the forecasting period. This is attributed to high prevelance of diabetic patients in this region.

Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Digital Therapeutics Market

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts